CME Sponsor:
Imedex

Location:
Sheraton Grande Walkerhill
Seoul, South Korea

Faculty Chairs:
Anthony TC Chan, MD, FRCP
The Chinese University of Hong Kong
Hong Kong SAR, People’s Republic of China

Stephen L. Chan, MD
The Chinese University of Hong Kong
Hong Kong SAR, People’s Republic of China

Alex Y. Chang, MD
John Hopkins Singapore International Medical Centre
Singapore, Singapore

Li-Tzong Chen, MD, PhD
National Institute of Cancer Research,
National Health Research Institutes
Tainan, Taiwan

Ann-Lii, Cheng, MD, PhD
National Taiwan University Hospital
Taipei, Taiwan

Mario Dicato, MD
Luxembourg Medical Center
Luxembourg, Luxembourg

Haruhiro Inoue, MD, PhD
Showa University Northern Yokohama
Hospital Digestive Disease Center
Yokohama, Japan

Hwoon-Yong Jung, MD, PhD, AGAF
Asan Medical Center
University of Ulsan College of Medicine
Seoul, South Korea

Yoon-Koo Kang, MD, PhD
Congress Chair
Asan Medical Center
University of Ulsan College of Medicine
Seoul, South Korea

Jong Hoon Kim, MD, PhD
Asan Medical Center
University of Ulsan College of Medicine
Seoul, South Korea

Song, Chel Kim, MD
Asan Medical Center
University of Ulsan College of Medicine
Songpa-gu, Seoul, South Korea

Tae Won Kim, MD, PhD
Asan Medical Center
University of Ulsan College of Medicine
Seoul, South Korea

Jin Li, MD, PhD
Fudan University Shanghai
Cancer Center
Shanghai, China

Brigette Ma, MBBS, FRACP
The Chinese University of Hong Kong
Hong Kong SAR, People’s Republic of China

Atsushi Ohtsu, MD, PhD
National Cancer Center Hospital East
Kashiwa, Japan

Takuji Okusaka, MD, PhD
National Cancer Center Hospital
Tokyo, Japan

Joong-Won Park, MD, PhD
Center for Liver Cancer National Cancer Center
Goyang, South Korea

Young Suk Park, MD
Samsung Medical Center
Sungkyunkwan University School of Medicine
Seoul, South Korea

Jinsil Seong, MD, PhD
Yonsei University Medical College
Seoul, South Korea

Aesun Shin, MD, PhD
National Cancer Center
Gyonggi-do, South Korea

Kohei Shitara, MD
Aichi Cancer Center Hospital
Nagoya-shi, Aichi-Ken, Japan

Virote Sriuranpong, MD, PhD
Chulalongkorn University
The Chulalongkorn University and The King Chulalongkorn Memorial Hospital
Bangkok, Thailand

Eric Van Cutsem, MD, PhD
Congress Chair
University Hospital Gasthuisberg
Leuven, Belgium

Han-Kwang Yang, MD, PhD, FACS
Seoul National University Hospital
Seoul, South Koreaa

Number of Credits:
TBA
 
Registration:
Early (before 6/21/11) $249.00
Discount (before 8/18/11) $329.00
Regular (after 8/18/11)$399.0
Nurses/Residents/Students (proof of eligibility must accompany registration; cannot be combined with any other discounts) $50.00
KACO/KCSG (proof of eligibility must be faxed to 1-678-242-0920 OR emailed to meetings@imedex.com before 8/18/11) $0.00

Please register onsite after 8/18/2011. Contact Imedex at (678) 242 0906 or visit our website to ensure the course is being held as scheduled and to confirm that the meeting is not full.

Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.

For easy registration, feel free to call (512) 708-4678.

Cancellation:
For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 18 August 2011. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 18 August 2011.

Link

Detailed Description:
This educational activity is designed for practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract. This 2-day scientific meeting will provide state-of-the-art information on the multi-disciplinary management of patients with gastrointestinal cancer including contemporary treatment options, surgical techniques, and current trends and controversies.

Objectives:
After successful completion of this course, attendees should be able to:
•    Discuss evolving multimodality treatment options for patients with esophageal cancer
•    Describe emerging treatment approaches for gastrointestinal stromal tumors (GIST)
•    Evaluate the diagnostic tools and endoscopic techniques used to detect and manage early gastric cancer
•    Select the most appropriate therapeutic strategy for gastric cancer
•    Integrate advances in systemic and local therapies into clinical practice to treat hepatobiliary tumors
•    Summarize new and emerging treatment options for pancreatic cancer
•    Improve the outcomes of patients with localized colorectal disease by employing most favorable adjuvant therapy
•    Comment on the role of cytotoxic treatment regimens, angiogenesis inhibitors and epidermal growth factor receptor (EGFR) inhibitors in advanced or metastatic colorectal cancer
•    Assess the clinical implications of using molecular markers as screening and prognostic tools for colorectal cancer
•    Review the most clinically relevant data recently presented regarding upper gastrointestinal and colorectal cancer management
•    Comment on surgical techniques used to treat various gastrointestinal cancers